Based on the iShares Biotechnology ETF stock forecast from 0 analysts, the average analyst target price for iShares Biotechnology ETF is not available over the next 12 months. iShares Biotechnology ETF’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of iShares Biotechnology ETF is Bearish, which is based on 1 positive signals and 3 negative signals. At the last closing, iShares Biotechnology ETF’s stock price was USD 136.10. iShares Biotechnology ETF’s stock price has changed by -2.85% over the past week, -5.48% over the past month and +15.37% over the last year.
Analyst Ratings
Target Price Action
Rating Action
Analyst
Rating
Price
Date
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
What not to like
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Below median total returns
The company has under performed its peers on annual average total returns in the past 5 years.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Add to Watchlists
loading..
Download Confirmation
Premium customers can only download records visible on the current page view, while Platinum customers can download the first 1000 records.
Paid-only feature
CSV downloads are only available for paying customers.
Thank you for Sharing your Stock Targets for IBB !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
